Vildagliptin
CAS:274901-16-5
Molecular formula:C17H25N3O2
Molecular weight:303.399
Product description:Vildagliptin (previously identified as LAF237, trade names Zomelis, Galvus) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
For more information OR other specifications of the products, please contact us.
Send Enquiry Online
For more information OR other products. Please contact us by Email, Tel or Send online enquiry. We will reply you as soon as possible.
1. E-mail: se(at)serebiomedical.com
2. Tel: +1 571 572 9408
3. WhatsApp: +1 571 572 9408
If you are interested in our product, want to know more about product information, please contact us, we are professional products manufacturers, our price concessions, professional level produce things cheap beauty products, welcomed the consultation.
